Biemans, Barbara,Guba, Wolfgang,Jaeschke, Georg,Lindemann, Lothar,O'Harra, Fionn,Ricci, Antonio,Rueher, Daniel,Vieira, Eric
申请号：
HRP20191139
公开号：
HRP20191139T1
申请日:
2019.06.21
申请国别(地区):
HR
年份:
2019
代理人:
摘要：
The present invention relates to positive allosteric modulators (PAMs) of metabotropic glutamate receptor 4 (mGluR4) that may be used for the treatment of conditions such as Parkinson's disease, anxiety, emesis, obsessive compulsive disorder, autism, neuroprotection, cancer, depression and diabetes type 2.
